Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mereo BioPharma (MREO) Gross Profit (2023 - 2025)

Mereo BioPharma (MREO) has disclosed Gross Profit for 2 consecutive years, with $400000.0 as the latest value for Q2 2025.

  • Quarterly Gross Profit changed N/A to $400000.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $400000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $367000.0 for FY2025, N/A changed from the prior year.
  • Gross Profit for Q2 2025 was $400000.0 at Mereo BioPharma, down from $1.3 million in the prior quarter.
  • The five-year high for Gross Profit was $5.6 million in Q2 2023, with the low at -$347000.0 in Q1 2023.